Activity of intrapleural recombinant gamma‐interferon in malignant mesothelioma

110Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Twenty‐two consecutive patients with malignant diffuse pleural mesothelioma were treated with recombinant gamma‐interferon by the intrapleural route. Diagnosis was made by thoracoscopic examination and all cases were confirmed by the French Mesothelioma Panel of Pathologists. Patients were staged based on thoracoscopic examination and computed tomography (CT) scan: 12 patients were classified as Stage I and 10 were Stage II. A solution of gamma‐interferon (40 × 106 U) was infused twice a week over 2 months. Every patient experienced fever. One patient had a Grade 2 leukopenia and one patient suffered from pleural empyema. Response evaluation was based on the following: (1) CT scan performed 2 weeks after treatment ended, and (2) repeat thoracoscopic examination with histopathologic verification in nine patients who had demonstrated a stabilization or a regression of the disease on CT scan. From the original group, 19 patients could be evaluated. Four complete thoracoscopic histopathologic responses and one partial response were observed in Stage I patients (56%). One partial response was observed in Stage II patients. Copyright © 1991 American Cancer Society

References Powered by Scopus

Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients

475Citations
N/AReaders
Get full text

Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: A retrospective study of 332 patients

338Citations
N/AReaders
Get full text

Malignant mesothelioma 1982: Review of 4710 published cases

278Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The Interferons: Mechanisms of Action and Clinical Applications

651Citations
N/AReaders
Get full text

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

546Citations
N/AReaders
Get full text

Management of malignant pleural effusions

488Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Boutin, C., Viallat, J. R., van Zandwijk, N., Douillard, J. T., Paillard, J. C., Guerin, J. C., … Brandely, M. (1991). Activity of intrapleural recombinant gamma‐interferon in malignant mesothelioma. Cancer, 67(8), 2033–2037. https://doi.org/10.1002/1097-0142(19910415)67:8<2033::AID-CNCR2820670804>3.0.CO;2-8

Readers' Seniority

Tooltip

Researcher 3

50%

PhD / Post grad / Masters / Doc 2

33%

Professor / Associate Prof. 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

57%

Philosophy 1

14%

Sports and Recreations 1

14%

Chemistry 1

14%

Save time finding and organizing research with Mendeley

Sign up for free